New sling offers hope for women with stress incontinence
NCT ID NCT04115605
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 598 women who received the Altis Single Incision Sling, a minimally invasive mesh device, to treat stress urinary incontinence. Researchers tracked how well the sling worked and monitored safety over 12 and 36 months after implantation. The goal was to see if the device improves symptoms and has an acceptable safety profile in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Altis Single Incision Sling (a permanently implanted synthetic mesh sling)
What this could lead to
If successful, this could confirm that the Altis sling is a safe and effective long-term option for controlling stress urinary incontinence in women.
What could go wrong
The study was terminated early, so results may be incomplete. As an observational study, it cannot prove cause and effect, and individual results may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY INCONTINENCE,STRESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Armand Brillart Hospital
Nogent-sur-Marne, 94130, France
-
Azienda USL Valle d'Aosta
Aosta, 11100, Italy
-
CH Libourne
Libourne, 33500, France
-
CH Paul Ardier
Issoire, 63503, France
-
CHI Poissy Saint Germain en Laye
Poissy, 78303, France
-
CHRU Hotel Dieu
Angers, 49933, France
-
CHU Clermont Ferrand
Clermont-Ferrand, 63003, France
-
CHU Pellegrin-Urology Departement
Bordeaux, 33076, France
-
CHU Pellegrin_Gyneacology Departement
Bordeaux, 33076, France
-
Centre Clinical
Soyaux, 16800, France
-
Centre Hospitalier Saint Louis
La Rochelle, 17019, France
-
Clinique Ambroise Paré
Toulouse, 31082, France
-
Clinique Champeau Mediterranée
Béziers, 34535, France
-
Clinique Mutualiste de la Porte de l'Orient
Lorient, 56100, France
-
Clinique Rhône Durance
Avignon, 84082, France
-
Clinique Saint Jean Languedoc
Toulouse, 31077, France
-
Clinique Saint-Amé
Lambres-lez-Douai, 59552, France
-
Clinique Saint-Charles
La Roche-sur-Yon, 85106, France
-
Clinique St Hilaire
Rouen, 76044, France
-
Clinique du Mail La Rochelle
La Rochelle, 17087, France
-
Frauenärzte im Seenland
Gunzenhausen, 91710, Germany
-
Hosital Clinico de Valladolid
Valladolid, 47003, Spain
-
Hospital Univeritario Joan XXIII
Tarragona, 43005, Spain
-
Hospital Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital la Fé
Valencia, 46026, Spain
-
Hôpital Victor Jousselin
Dreux, 28102, France
-
Hôpital du Pays d'Autan
Castres, 81108, France
-
Hôpital privé Jacques Cartier
Massy, 91349, France
-
Klinikum Memmingen
Memmingen, 87700, Germany
-
Klinikum Worms gGmbH
Worms, 67550, Germany
-
Polyclinique Jean Villars
Bruges, 33523, France
-
Pôle Santé Léonard de Vinci
Chambray-lès-Tours, 37170, France
-
UZ Leuven
Leuven, 3000, Belgium